$Aehr Test(AEHR.US) surged 28% today, with earnings again beating expectations—Q4 FY revenue of $18.8M, up 34% YoY, and EPS of $0.11 directly smashing previous expectations that were close to breakeven. More importantly, it provided FY27 revenue guidance of $130M to $150M, corresponding to 160% to 200% growth.
Demand for wafer-level testing related to AI and electric vehicles is driving orders, with single-quarter bookings of $60.7M and a backlog exceeding $100M. The elasticity of small-cap semiconductor test equipment, when combined with better-than-expected guidance, creates this kind of explosive power, leading to a re-rating of valuations.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
